Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
The Journal of Infectious Diseases2009Vol. 201(1), pp. 32–41
Citations Over TimeTop 1% of 2009 papers
Tamara Pilishvili, Catherine Lexau, Monica M. Farley, James L. Hadler, Lee H. Harrison, Nancy M. Bennett, Arthur Reingold, Ann Thomas, William Schaffner, Allen S. Craig, Philip J Smith, Bernard Beall, Cynthia G. Whitney, Matthew R. Moore
Abstract
Dramatic reductions in IPD after PCV7 introduction in the United States remain evident 7 years later. IPD rates caused by serotype 19A and other non-PCV7 types have increased but remain low relative to decreases in PCV7-type IPD.
Related Papers
- → Multicenter Surveillance of Streptococcus pneumoniae Isolates From Middle Ear and Mastoid Cultures in the 13-Valent Pneumococcal Conjugate Vaccine Era(2015)68 cited
- → Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization by Streptococcus pneumoniae--Alaska, 2008-2012(2013)47 cited
- → Noninvasive Streptococcus pneumoniae Serotypes Recovered from Hospitalized Adult Patients in the United States in 2009 to 2012(2015)31 cited
- → InvasiveStreptococcus pneumoniaein Children, Malawi, 2004–2006(2011)27 cited
- → Serotypes of Streptococcus pneumoniae Isolates from Children with Invasive Pneumococcal Disease in Turkey: Baseline Evaluation of the Introduction of the Pneumococcal Conjugate Vaccine Nationwide(2011)16 cited